Saffron for Mild-to-moderate depression and Saffron
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
Saffron for Mild-to-moderate depression
Evidence grade B — ~30 mg/day
Grade B1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
Saffron
Surprisingly solid for low mood at ~30 mg/day — a rare botantical antidepressant with real trials, carrying the serotonergic caveat.
Grade B2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Saffron for Mild-to-moderate depression | Saffron |
|---|---|---|
| Mild-to-moderate depression | Evidence grade BModerate effectmixed~30 mg/day | Evidence grade BModerate effectmixed~30 mg/day |
Graded only in Saffron for Mild-to-moderate depression
None — every outcome it grades is graded in both.
Graded only in Saffron
- Anxiety / PMS Small effectEvidence grade C
Conditions
Only in Saffron for Mild-to-moderate depression
None.
Only in Saffron
- Depression (mild-moderate) ImprovesEvidence grade B
What each entry says about the other
- Saffron for Mild-to-moderate depression’s entry · Goes with: Read the full Saffron monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.